Analyst Ratings for Dicerna Pharmaceuticals (DRNA) [Neutrals]
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 3.8 / 10
Percentile Rank: 43%
Rating Score: 3.8 / 10
Percentile Rank: 43%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/9/2021 | Chardan Capital Markets | Keay Nakae | Downgrade | Neutral (Buy) |
38.25 (N/A) |
38.16 (38.22) |
0.16% | Details |
| 11/19/2021 | RBC Capital | Luca Issi | Downgrade | Sector Perform (Outperform) |
38.25 (30.00) |
21.28 (38.22) |
79.61% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
